Geode Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-142,196
| Closed | -$59.8K | – | 4576 |
|
|
2024
Q4 | $59.8K | Buy |
142,196
+51,316
| +56% | +$42.9K | ﹤0.01% | 4213 |
|
|
2024
Q3 | $179K | Sell |
90,880
-39,509
| -30% | -$150K | ﹤0.01% | 3940 |
|
|
2024
Q2 | $696K | Buy |
130,389
+102,549
| +368% | +$428K | ﹤0.01% | 3451 |
|
|
2024
Q1 | $83.5K | Buy |
27,840
+3,786
| +16% | +$17.7K | ﹤0.01% | 4217 |
|
|
2023
Q4 | $151K | Sell |
24,054
-3
| -0% | -$23 | ﹤0.01% | 4040 |
|
|
2023
Q3 | $532K | Buy |
24,057
+23,697
| +6,583% | +$618K | ﹤0.01% | 3582 |
|
|
2023
Q2 | $2.54K | Hold |
360
| – | – | ﹤0.01% | 4748 |
|
|
2023
Q1 | $16.6K | Sell |
360
-6
| -2% | -$655 | ﹤0.01% | 4725 |
|
|
2022
Q4 | $52K | Buy |
366
+58
| +19% | +$11.9K | ﹤0.01% | 4581 |
|
|
2022
Q3 | $173K | Hold |
308
| – | – | ﹤0.01% | 4295 |
|
|
2022
Q2 | $248K | Sell |
308
-8
| -3% | -$11.9K | ﹤0.01% | 4138 |
|
|
2022
Q1 | $828K | Buy |
316
+13
| +4% | +$27.6K | ﹤0.01% | 3701 |
|
|
2021
Q4 | $782K | Hold |
303
| – | – | ﹤0.01% | 3831 |
|
|
2021
Q3 | $1.39M | Buy |
303
+4
| +1% | +$20.1K | ﹤0.01% | 3520 |
|
|
2021
Q2 | $1.78M | Buy |
299
+39
| +15% | +$252K | ﹤0.01% | 3317 |
|
|
2021
Q1 | $2.1M | Buy |
260
+68
| +35% | +$720K | ﹤0.01% | 3232 |
|
|
2020
Q4 | $1.19M | Sell |
192
-3
| -2% | -$18.4K | ﹤0.01% | 3315 |
|
|
2020
Q3 | $1.32M | Buy |
195
+53
| +37% | +$393K | ﹤0.01% | 3099 |
|
|
2020
Q2 | $899K | Sell |
142
-10
| -7% | -$42.5K | ﹤0.01% | 3173 |
|
|
2020
Q1 | $493K | Buy |
152
+76
| +100% | +$316K | ﹤0.01% | 3277 |
|
|
2019
Q4 | $443K | Buy |
76
+1
| +1% | +$9.45K | ﹤0.01% | 3542 |
|
|
2019
Q3 | $941K | Sell |
75
-1
| -1% | -$8.03K | ﹤0.01% | 3257 |
|
|
2019
Q2 | $634K | Sell |
76
-12
| -14% | -$141K | ﹤0.01% | 3382 |
|
|
2019
Q1 | $1.16M | Buy |
88
+13
| +17% | +$221K | ﹤0.01% | 3103 |
|
|
2018
Q4 | $1.13M | Buy |
75
+3
| +4% | +$70.5K | ﹤0.01% | 3055 |
|
|
2018
Q3 | $2.7M | Buy |
72
+6
| +9% | +$198K | ﹤0.01% | 2722 |
|
|
2018
Q2 | $2.57M | Buy |
66
+39
| +144% | +$1.48M | ﹤0.01% | 2711 |
|
|
2018
Q1 | $872K | Hold |
27
| – | – | ﹤0.01% | 3188 |
|
|
2017
Q4 | $554K | Buy |
27
+8
| +42% | +$165K | ﹤0.01% | 3318 |
|
|
2017
Q3 | $397K | Hold |
19
| – | – | ﹤0.01% | 3439 |
|
|
2017
Q2 | $304K | Sell |
19
-5
| -21% | -$100K | ﹤0.01% | 3537 |
|
|
2017
Q1 | $643K | Buy |
24
+1
| +4% | +$28.1K | ﹤0.01% | 3215 |
|
|
2016
Q4 | $616K | Buy |
23
+1
| +5% | +$30.8K | ﹤0.01% | 3196 |
|
|
2016
Q3 | $809K | Hold |
22
| – | – | ﹤0.01% | 3059 |
|
|
2016
Q2 | $858K | Buy |
22
+2
| +10% | +$90.3K | ﹤0.01% | 2980 |
|
|
2016
Q1 | $987 | Hold |
20
| – | – | ﹤0.01% | 2886 |
|
|
2015
Q4 | $1.07M | Buy |
20
+12
| +150% | +$647K | ﹤0.01% | 2881 |
|
|
2015
Q3 | $349K | Hold |
8
| – | – | ﹤0.01% | 3403 |
|
|
2015
Q2 | $613K | Buy |
8
+1
| +14% | +$86.8K | ﹤0.01% | 3114 |
|
|
2015
Q1 | $543K | Buy |
7
+1
| +17% | +$92.8K | ﹤0.01% | 3163 |
|
|
2014
Q4 | $536K | Buy |
6
+1
| +20% | +$82.4K | ﹤0.01% | 3158 |
|
|
2014
Q3 | $488K | Buy |
+5
| New | +$465K | ﹤0.01% | 3184 |
|
Geode Capital Management's TTOO Position: Q1 2025 in Review
Geode Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 142,196 shares — an estimated $59.8K sold.
Geode Capital Management first reported a position in TTOO in Q3 2014 and held it in 42 quarters. The position peaked at $2.7M in Q3 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Geode Capital Management reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Geode Capital Management sold 142,196 T2 Biosystems, Inc shares in Q1 2025, an estimated $59.8K.
- Geode Capital Management first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 42 quarters.
- Geode Capital Management's T2 Biosystems, Inc position peaked at $2.7M in Q3 2018.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.